Several studies have identified CNN1 as a tumor suppressor, noting its decreased expression in various cancers, such as ovarian cancer, hepatocellular carcinoma, breast cancer, and colorectal cancer (CRC) [36–39]. Here, CNN1 is linked to breast cancer.